GILEAD SCIENCES, INC. (GILD) Operating cash flow 2016–2025
GILEAD SCIENCES, INC. (GILD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$10.0BFY2025 · since FY2016: $17.0B → $10.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.0B | -7.5% |
| FY2024 | $10.8B | +35.2% |
| FY2023 | $8.0B | -11.8% |
| FY2022 | $9.1B | -20.3% |
| FY2021 | $11.4B | +39.4% |
| FY2020 | $8.2B | -10.7% |
| FY2019 | $9.1B | +8.9% |
| FY2018 | $8.4B | -29.4% |
| FY2017 | $11.9B | -30.2% |
| FY2016 | $17.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GILD financial trends
GILD RevenueGILD Net incomeGILD Net marginGILD Gross profitGILD Gross marginGILD Operating incomeGILD Operating marginGILD Free cash flowGILD Capital expendituresGILD Return on equityGILD Stock buybacksGILD Dividends paidGILD Total assetsGILD Total liabilitiesGILD Shareholders’ equityGILD overview →